BioCentury
ARTICLE | Product Development

Apex takes on the shock in sepsis

March 24, 1997 8:00 AM UTC

A hemoglobin derivative is the latest biotech foray toward the industry black hole of sepsis. But Joseph DeAngelo, the co-inventor of the technology, emphasizes that the treatment is for shock

A hemoglobin derivative is the latest biotech foray toward the industry black hole of sepsis. But Joseph DeAngelo, the co-inventor of the technology, emphasizes that the treatment is for shock...